The purpose of the study is to determine differences in levels of serum chemokines from patients undergoing treatment with Boceprevir. The aim is to determine if non-responders have significantly different levels of chemokines than responders.
Patients undergoing standard of care at the UNC Liver Center are consented for collection of an additional serum sample under the UNC Liver Center serum and tissue bank study. These samples will be used to analyze differences in serum chemokines across responders and non-responders.
Study Type
OBSERVATIONAL
University of North Carolina Liver Center
Chapel Hill, North Carolina, United States
Level (ng/mL) of serum chemokines.
Compare levels of serum chemokines across Boceprevir responders (SVR) and non-responders for both Baseline (\<=6-months pre-treatment) and Post-treatment (\<=6-months post-treatment).
Time frame: Baseline: <=6 months prior to start of treatment and Post-treatment: <=6-months after the last dose
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.